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Background
The apicomplexan parasite Toxoplasma gondii is an obligate intracellular human pathogen causing toxoplasmosis predominantly in immune-compromised hosts such as cancer and transplant patients as well as patients with AIDS [1] . A specific cGMP-dependent protein kinase (TgPKG) which appears to be crucial for host invasion has been identified in T. gondii and related coccidial protozoa [2] . However, detailed structural and biochemical analyses have been hampered due to the inability to functionally express these kinases in high yields in systems other than their parasite host organisms.
Results
Here we describe the expression, purification and initial characterization of the 911 amino acid (103 kDa) Histagged type II isoform of TgPKG using a bacterial source. A phylogenetic analysis further reveals that TgPKG2 belongs to an evolutionarily distinct sub-group of the AGC-kinase family. The overall domain composition of TgPKG2 substantially deviates from its mammalian cousins at two regions. First, the 196 amino acid Nterminal/auto-inhibitory domain bears no resemblance with any other PKG subfamily, and secondly the kinase consists of three cGMP binding sites with the third binding sites separated from the others by 135 amino acids. Consequently, TgPKG2 illustrated a remarkable level of cooperativity (n H = 2.9) accompanied by a 200-400 fold cGMP-mediated activation utilizing the common PKG substrate TQAKRKKSLAMA (K m = 9 µM).
The associated activation constant was 1.7 µM which is in full agreement with the isoforms obtained from T. gondii parasite extract [3] . Interestingly, TgPKG2 was completely insensitive to cAMP (K a » 100 µM). Recently, the trisubstituted pyrrole 4-[2-(4-fluorophenyl)-5-(1-methylpiperidine-4-yl)-1H pyrrol-3-yl] pyridine (Compound 1) was shown to exhibit anticoccidial kinase activity [3, 4] . Compound 1 blocked kinase activity of TgPKG2 with high potency (IC 50 = 59 nM) and high selectivity; the mammalian type Iα PKG showed an approximately 1000-fold reduced IC 50 of 45 µM.
Conclusion
This work demonstrates the first catalytically active expression of any cGMP-dependent protein kinase from E. coli and may provide a new platform for the functional and structural analysis, as well as evolutionary history, of PKG isoforms from apicomplexan parasites.
